Here are six quick facts:
1. The shares were sold at an average price of $18.52, for a total of $1.32 million.
2. Post the transaction, Mr. Nanavaty directly owns 134,534 shares of the company’s stock, valued at approximately $2.49 million.
3. The company has a 52-week low of $11.10 and a 52-week high of $18.62.
4. The stock’s 50-day moving average is $17 and its 200-day moving average is $15.
5. The company’s market cap is $24.55 billion.
6. The stock has a consensus rating of “buy” and an average price target of $18.42.
More articles on GI/endoscopy:
FDA clears 2 GI/endoscopy devices in May
Gastro Health launches online support community for GI patients: 4 key notes
Dr. Peter Cotton leads national study of gallbladder surgery
